Company Filing History:
Years Active: 2018
Title: Innovations by Abiral Regmi in Cardiovascular Disease Detection
Introduction
Abiral Regmi is an innovative inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of biomedical engineering, particularly in the detection of cardiovascular diseases. His work focuses on developing methods that enhance the accuracy and efficiency of disease biomarker analysis.
Latest Patents
Abiral Regmi holds a patent for a method designed to detect cardiovascular disease biomarkers. This method involves analyzing the concentration of a cardiovascular disease (CVD) biomarker in a liquid sample. The process includes applying the liquid sample to a biosensor, which consists of a transistor with specific terminals and a reactive electrode. The electrode is equipped with a receptor that binds specifically to the CVD biomarker. The method further involves applying a voltage pulse and monitoring the response current to analyze the biomarker concentration effectively.
Career Highlights
Abiral Regmi is affiliated with Tsinghua University, where he continues to advance his research in biomedical applications. His work has garnered attention for its potential impact on early detection and diagnosis of cardiovascular diseases.
Collaborations
Abiral has collaborated with notable colleagues, including Yu-Lin Wang and Gwo-Bin Lee, who share his commitment to innovation in health technology.
Conclusion
Abiral Regmi's contributions to the detection of cardiovascular disease biomarkers represent a significant advancement in medical technology. His innovative methods have the potential to improve diagnostic processes and patient outcomes in the field of cardiovascular health.